Entering text into the input field will update the search result below

Moderna, Inc.'s (MRNA) Management Presents at Chardan 5th Annual Genetic Medicines Conference (Transcript)

Oct. 05, 2021 3:17 PM ETModerna, Inc. (MRNA)4 Comments
SA Transcripts profile picture
SA Transcripts

Moderna, Inc. (NASDAQ:MRNA) Chardan 5th Annual Genetic Medicines Conference October 5, 2021 1:00 PM ET

Company Participants

Stephen Hoge - President

Conference Call Participants

Geulah Livshits - Chardan Capital Markets

Geulah Livshits

Hello. And it's now my pleasure to introduce our next fireside chat guest, Dr. Stephen Hoge, President of Moderna. Stephen, thank you again for joining us today. And maybe let's start off by a big picture item. The last year, when you participated in our conference, Moderna was a Phase 3 company and now millions of people have received the Moderna COVID-19 vaccine. We've seen the pipeline advance and you've announced a number of research and manufacturing initiatives.

Question-and-Answer Session

Q - Geulah Livshits

So before we talk about these topics in a bit more detail, can you comment at a high level on Moderna's trajectory and priorities going forward?

Stephen Hoge

Well, thank you, and thanks again for having me back. I enjoyed it so much last year and the year before. So this will be an exciting chance to reprice where we've been. It has been a very busy year, as you described. I think I talk least about our progress in COVID, which is a place that's been well covered and maybe focus a lot on all of the other progress that's been happening in our clinical development pipeline.

As we've announced throughout the year, we've had a number of key transitions, a few that I'd highlight in the respiratory vaccine space to start out, which is, we've been moving forward with both our flu and RSV vaccines. These are respiratory vaccines that we think we will eventually use in combinations, both for older adults and pediatric populations. We've been advancing them very quickly in both of those populations and actually have completely enrolled those studies and announced at a recent -- at our

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.